Quand ils ouvriront une session pour la première fois après le 31 mars 2024, tous les utilisateurs d'un compte Inforoute devront reconfirmer leur acceptation des contrats de licence et des conditions d'utilisation. En savoir plus >

Partager :

file Medications and Immunizations Draft Profiles are Complete and Ready for Review

  • Messages : 181
il y a 3 ans 11 mois #5860 par Igor Sirkovich
Dear members of the Medication Management group,

All the Canadian Core Medications and Immunizations draft profiles are complete. Please review these draft profiles at build.fhir.org/ig/scratch-fhir-profiles/CA-Core/artifacts.html and provide feedback under the FHIR Implementers forum thread .

We are going to cancel our Medications & Immunizations weekly calls and will consider setting up a review meeting if we get any feedback that needs to be discussed on a call.

One outstanding question is whether there is a need to create a new extension to represent a 'DPD Company' name (as opposed to the existing 'manufacturer' element) for both Medication and Immunization profiles.

A 'DPD Company' name, as used in the Health Canada DPF, indicates the organisation (company) that holds the authorization to place the product on the market in Canada. This may not be the company that has manufactured the product, but it is the company that holds the legal responsibility for the use of the product in Canada and should be the same as the company named on the product label/packaging.

Connexion ou Créer un compte pour participer à la conversation.

Modérateurs: Linda MonicoSeema Nayani

Logo d'InfoCentral

La santé numérique à votre service

 

Transformer les soins de santé au Canada grâce aux technologies de l'information sur la santé.